There is a lot going on in research and development for new cancer treatments, including immunotherapies. I attended a patient summit in Chicago, in August, put on by the Cancer Research Institute (US). It was very informative and they had a researcher at that summit that was particularly focused on ovarian cancer. They are live-streaming a summit on Sept. 23. It is free and anyone can register at cripatientsummit-livestream.eventbrite.com. It will be on Sat., Sept. 23, 2017 from 10:00 - 3:30 EDT. I do not believe that an ovarian cancer researcher will be at this summit, but the general information is worth listening to.
2
Comments
Hi @AndreaB. Very interesting results with recurrences - 4 yrs vs. 18 months! Are you still being followed for the trial? If so, did they make any comment about the length of your remission?
Today we took my mom to Princess Margaret and she was offered a trial similar to yours, but with the addition of Keytruda to the DPX-Survivac/low-dose cyclophosphamide combo. She is not sure what to do yet... it's all so overwhelming for her. It feels like a gamble... go with an known/tested chemo option that has a 20% response rate, or go with something completely new that shows promise but that we don't know much about. It would be good to know if any of these immunotherapy drugs on their own, or a combination of them, have better results.